Correlation between dietary polyunsaturated fatty acids and plasma homocysteine concentration in vitamin B6-deficient rats

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 2, 2005, Pages 94-99

  Cabrini, L ^a   Bochicchio, D ^b   Bordoni, A ^a   Sassi, S ^c   Marchetti, M ^a   Maranesi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Exp Institute of Zootechnics   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dietary PUFA; Homocysteine; Vitamin B6; 6 desaturase

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; FOLIC ACID; HOMOCYSTEINE; LONG CHAIN FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PYRIDOXINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; HOMOCYSTINURIA; HYPERHOMOCYSTEINEMIA; LIPID COMPOSITION; LIPID LIVER LEVEL; MALE; NONHUMAN; PYRIDOXINE DEFICIENCY; RAT; RISK ASSESSMENT;

EID: 19044367645     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2004.11.002     Document Type: Article

References (28)

1. McKully KS. Homocysteine and vascular diseases. Nat Med 1996;2:386-9.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
3. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases. Circulation 1999;99:178-82.
4. Kang SS, Wong PKW, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
5. Kraus JP, Oliveriusova J, Sokolova J, Kraus E, Vlcek C, de Franchis R, et al. The human cystathionine beta-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms. Genomics Sep 1998;1552(3):312-24.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
7. Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci U S A 2003;100(25):15089-94.
8. Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC. Homocysteine and risk of coronary artery disease: folate is the important determinant of plasma homocysteine concentration. Nutrition 2003;19:577-83.
9. Verhoef P, Stampfer MJ, Buring JE, Graziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-59.
10. Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J. Serum total homocysteine concentrations in children and adolescents: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Nutr 2003;133(8):2643-9.
11. De Gomez Dumm NT, Giammona AM, Touceda LA. Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine. Lipids Health Dis 2003;2(1):7.
12. Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Langer K, et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995;6:121-5.
13. Robinson K, Mayer EL, Miller D, Green R, van Lente F, Gupta A, et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 1995;92:2825-30.
14. Kok FJ, Schrijver J, Hofman A, Witteman JC, Kruyssen DA, Remme WJ, et al. Low vitamin B6 status in patients with acute myocardial infarction. Am J Cardiol 1989;63:513-6.
15. Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 2004;79(6):992-8.
16. Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations. Circulation 1998;97:437-43.
17. Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 1998;65(4):544-50.
18. Brattström L, Stavenow L, Galvard H, Nilsson-Ehle P, Berntorp E, Jerntorp P, et al. Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphate. Scand J Clin Lab Invest 1990;50:873-7.
19. 6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes. Prostaglandins Leukotr Ess Fatty Acids 1998;58:417-20.
20. 6 deficiency affects antioxidant defences in rat liver and heart. Biochem Mol Biol Int 1998;46:689-97.
21. 6 and fish oil on lipid composition and antioxidant defences in rat tissues. Prostaglandins Leukotr Ess Fatty Acids 2001;64:265-71.
22. Furth-Walker D, Leibman D, Smolen A. Changes in pyridoxal phosphate and pyridoxamine phosphate in blood, liver and brain in the pregnant mouse. J Nutr 1989;119:750-6.
23. Cuniff P, editor. Vitamin B6 in food extracts. Microbiological method. Official Methods of Analysis. Association of official Analytical Chemist. 17th ed. vol II. Washington, DC; 1995. p. 51-3.
24. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;256:497-509.
25. Stoffel W, Chu F, Ahrens Jr EH. Analysis of long chain fatty acids by gas-liquid chromatography. Anal Chem 1959;31:307-8.
26. Cunnane SC, Manku MS, Horrobin DF. Accumulation of linoleic and gamma-linolenic acids in tissue lipids of pyridoxine-deficient rats. J Nutr 1984;114:1754-61.
27. 6 deficient rats. Biochem Int 1990;21:599-605.
28. Smolin LA, Benevenga NJ. Factors affecting the accumulation of homocyst(e)ine in rats deficient in vitamin B-6. J Nutr 1984;114:103-11.